
AVISE - Advanced Testing For Lupus and Autoimmune Disease
Learn more about detecting and diagnosing autoimmune disorders, including common lupus symptoms and other related diseases. We offer a variety of advanced lab tests including our …
AVISE Autoimmune Lab Tests
AVISE testing provides state-of-the-art insight to aid physicians in the diagnosis, prognosis and monitoring of autoimmune conditions.
Autoimmune Disease Testing - AVISE Tests
AVISE testing aims to change that through advanced diagnostic testing. With a two-tiered approach that is more sensitive and specific than autoimmune testing of the past, your doctor …
Advanced Diagnostic Test for Systemic Lupus Erythematosus
Delays in diagnosis can lead to increased morbidity, higher mortality rates, and escalating healthcare costs. AVISE CTD addresses the challenge of overlapping symptoms by providing …
Advanced Diagnostic Test For Lupus And Autoimmune Disease
AVISE CTD combines AVISE Lupus, a 10-marker diagnostic test designed to help rule-in or rule-out lupus, with an expanded connective tissue disease panel to aid in the differential diagnosis …
Testing for Diagnosis of Lupus and Autoimmune Disease - AVISE …
Learn more about diagnosing and monitoring autoimmune disorders, including common lupus symptoms and related diseases.
Tests for the Diagnosis, Prognosis and Monitoring of ... - AVISE Tests
AVISE testing helps rheumatologists optimize patient care through differential diagnosis, prognosis and management of complex autoimmune diseases.
In the AVISE Lupus algorithm, patients are first screened using an anti-dsDNA ELISA assay. Those who test positive are then confirmed with the Crithidia luciliaeIFA assay, a more …
AVISE Test FAQs for Providers
AVISE testing incorporates several biomarkers that are exclusively available from Exagen, including CB-CAPs and anti-CarP, as well as novel markers not widely available, including anti …
AVISE Lupus - Advanced Testing for Lupus Diagnosis - AVISE Tests
AVISE Lupus is a multi-marker algorithmic assay that delivers an index score indicative of SLE likelihood. Our proprietary two-tier algorithm integrates CB-CAPs together with autoantibody …